Antipsychotic Drugs in Nursing Homes
The use and ethics of antipsychotic drugs in nursing homes is an ongoing discussion. Learn why these medications are ...
Opinion - Is the FDA contributing to the homelessness crisis?
The FDA's REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...
In RFK Jr., drugmakers face an antagonist with regulatory power
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
FDA grants orphan drug designation to potential treatment of STXBP1 developmental and epileptic encephalopathy
Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...
FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
STAT22h
FDA commissioner: We need action and higher-quality research on ultra-processed foods
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...